News Author: HT Staff Publish date: August 4, 2016
Photo by Rob Press
Manipulating metabolic events might reinvigorate exhausted T cells and complement the effects of checkpoint inhibitors in the tr...
News Author: HT Staff Publish date: August 4, 2016
Clinical trials in children too often go uncompleted or unpublished, according to a pair of researchers. The duo evaluated nearly 560 pediatric tria...
News Author: HT Staff Publish date: August 4, 2016
ORLANDO—Results from an ongoing phase 1 study suggest fitusiran, a small interfering RNA therapeutic targeting antithrombin (AT), can restore hemostas...
News Author: HT Staff Publish date: August 3, 2016
infecting a red blood cell
Photo courtesy of St.
News Author: HT Staff Publish date: August 3, 2016
Next-generation sequencing (NGS) of cell-free DNA should be the method of choice to confirm the diagnosis of myelodysplastic syndromes (MDS), accordin...
News Author: HT Staff Publish date: August 3, 2016
Image from Salk Institute
New research suggests the type of founder cell used to generate induced pluripotent stem cells (iPSCs) does not affect th...
News Author: HT Staff Publish date: August 3, 2016
Photo by Rhoda Baer
Physicians may still prescribe a controversial drug combination despite safety concerns, according to a study published in Phar...
News Author: HT Staff Publish date: August 2, 2016
Image courtesy of NIGMS
ORLANDO—The gene therapy AMT-060 can reduce the need for factor IX (FIX) prophylaxis in patients with severe hemophilia B, ...
News Author: HT Staff Publish date: August 2, 2016
Photo courtesy of Baxalta
The US Food and Drug Administration (FDA) has approved the Baxject III reconstitution system for Adynovate, a pegylated r...
News Author: HT Staff Publish date: August 2, 2016
Photo courtesy of
Sahan Ranamukhaarachchi
A new microneedle drug monitoring system could one day replace invasive blood draws, according to resear...
News Author: HT Staff Publish date: August 2, 2016
Image by Eric Smith
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for the histone deacetylase (HDAC) inhib...
News Author: HT Staff Publish date: August 1, 2016
Image by Spencer Phillips
ORLANDO—An investigational gene therapy can safely reduce bleeding in patients with severe hemophilia A, a phase 1/2 stud...
News Author: HT Staff Publish date: August 1, 2016
A genetically engineered coagulation factor can reverse the effects of direct oral anticoagulants in vitro and in vivo, according to research publishe...
News Author: HT Staff Publish date: July 31, 2016
Photo courtesy of the
University of California Davis
Researchers say they have developed a targeted conjugate therapy that harnesses a monoclonal ...
News Author: HT Staff Publish date: July 30, 2016
Photo courtesy of
Muhammad Mahdi Karim
Officials have announced what is likely the first known occurrence of local mosquito-borne Zika virus trans...
